For Manufacturers
Doing Well by Doing Good
Reward innovative breakthroughs in medicine
With a sustainable revenue model
Ensure Drug Coverage
Steady Cash Flows
Expand Patient Access
Transform Drug Reimbursement
Subscription-based revenue for gene therapy
Our payment platform allows manufacturer to offer their drugs via a subscription model directly to health plan. We tap into the self-insured employer market representing over 100 million lives, which is often a coverage blind spot for most manufacturers. Our payment model incentivizes payers to collaborate, increasing patient access to gene therapies
